Bosentan (Tracleer®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS BOSENTAN? - Endothelin receptor antagonist - Document - PDFSEARCH.IO

First Page	Meta Content
	Bosentan (Tracleer®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS BOSENTAN? Add to Reading List Document Date: 2013-12-03 14:16:08 Open Document File Size: 213,94 KB Share Result on Facebook Company Accredo Health Group Inc. / Aetna / CVS Caremark / Actelion / / Facility Kaiser Permanente Specialty Pharmacy / Aetna Specialty Pharmacy / Walgreens Specialty Pharmacy / / IndustryTerm insurance plans / intrauterine device / insurance approval / food / / MedicalCondition significant liver disease / chronic illnesses / injury / disease / pulmonary arterial hypertension / significant kidney disease / pulmonary blood pressure / / MedicalTreatment contraception / Surgical treatment / blood transfusion / / Organization World Health Organization / Caring Voice Coalition / United States Food and Drug Administration / Medicare / / / Position physician / / Product ketoconazole / glyburide / Tracleer / rifampin / cyclosporine / / SocialTag Alcohols Bosentan Pyrimidines Hypertension Sitaxentan Pulmonary hypertension Endothelin receptor antagonist Sildenafil Actelion Chemistry

Bosentan (Tracleer®) Issued by PHA’s Scientific Leadership Council Information is based on the United States Food and Drug Administration drug labeling Last Updated November[removed]WHAT IS BOSENTAN?Add to Reading List